Drug Approval | March 07, 2025
Lupin Launches Rivaroxaban Tablets USP, 2.5mg in US
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Strokes are affecting approximately 1.8 million people annually
Dyslipidemia is a critical risk factor for cardiovascular diseases
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The company has received five final approvals
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Especially valuable for young patients with multiple blocks & underlying conditions that may render angioplasty procedures with drug-eluting stents ineffective
For the treatment of Superficial Femoral Artery
Subscribe To Our Newsletter & Stay Updated
